Immunologic aspect of ovarian cancer and p53 as tumor antigen.
Ovarian cancer represents the fifth leading cause of death from all cancers for women. During the last decades overall survival has improved due to the use of new chemotherapy schedules. Still, the majority of patients die of this disease. Research reveals that ovarian cancer patients exhibit significant immune responses against their tumor. In this review the knowledge obtained thus far on the interaction of ovarian cancer tumor cells and the immune system is discussed. Furthermore the role of p53 as tumor antigen and its potential role as target antigen in ovarian cancer is summarized. Based on the increased knowledge on the role of the immune system in ovarian cancer major improvements are to be expected of immunotherapy based treatment of this disease.
Nijman
H W
HW
Dept. of Gynaecologic Oncology, Groningen University Medical Center. h.w.nijman@og.umcg.nl
Lambeck
A
A
van der Burg
S H
SH
van der Zee
A G J
AG
Daemen
T
T